Controversy around nevirapine trials continues
The US Institute of Medicine (IOM), commissioned by the National Institutes of Health (NIH) to review its HIVNET 012 clinical trial, is set to release its findings in March.
Lancet Infectious Diseases
(2005). Controversy around nevirapine trials continues. Lancet Infectious Diseases, 5(2), 74.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/446